Journals / İstanbul Kanuni Sultan Süleyman Tıp Dergisi / 2018 / Cilt: 10 - Sayı: 1

Retrospective Analysis of Patients with Bonzai Toxicity Hospitalized in Intensive Care Unit

Yoğun Bakım Ünitesindeki Bonzai Zehirlenme Olgularının Retrospektif Analizi

Pages
7–11
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore suspect SK usage must be considered in the differential diagnosis in patients who were brought to the emergency service with symptoms of intoxication, and narcotic-test panel negativity, and symptomatic treatment must be started at an early stage.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Patients intoxicated by synthetic cannabinoid (SC) products named "Bonzai" or "Jamaica" in Turkey are very important problematic cases that must be followed up , and treated in intensive care units (ICUs).
📊
Key Findings & Data:In our study we aimed to discuss the clinical courses and outcomes of the cannabinoid-intoxicated patients treated in ICU.Material and Methods: The files of 19 patients (16 men, 3 women) who were followed up and treated in ICU of Ordu State Hospital between 2014 and 2017 were retrospectively scanned.Results: Median age of the patients whose SC usage was confirmed by themselves, their relatives and eyewitnesses was 20.1 years, and they consisted mostly of male patients.
💡
Conclusion & Impact:Therefore suspect SK usage must be considered in the differential diagnosis in patients who were brought to the emergency service with symptoms of intoxication, and narcotic-test panel negativity, and symptomatic treatment must be started at an early stage.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Patients intoxicated by synthetic cannabinoid (SC) products named "Bonzai" or "Jamaica" in Turkey are very important problematic cases that must be followed up , and treated in intensive care units (ICUs). In our study we aimed to discuss the clinical courses and outcomes of the cannabinoid-intoxicated patients treated in ICU.Material and Methods: The files of 19 patients (16 men, 3 women) who were followed up and treated in ICU of Ordu State Hospital between 2014 and 2017 were retrospectively scanned.Results: Median age of the patients whose SC usage was confirmed by themselves, their relatives and eyewitnesses was 20.1 years, and they consisted mostly of male patients. In SK -intoxicated patients we found mostly agitation, tachycardia, leukocytosis, increased levels of liver enzymes. In addition visual and auditory hallucinations, clouded consciousness, and coma were observed. Eighteen patients were discharged from the ICU and 1 patient died.Conclusion: SK intoxication has no specific treatment. Usually treatment is symptomatic and directed at developing complications. Nowadays multifaceted narcotic trade has led to marketing of new psychoactive drugs. Therefore suspect SK usage must be considered in the differential diagnosis in patients who were brought to the emergency service with symptoms of intoxication, and narcotic-test panel negativity, and symptomatic treatment must be started at an early stage.

Özet

Amaç: Türkiye'de "Bonzai" ya da "Jamaika'' olarak adlandırılan sentetik kannabinoidler (SK) ile zehirlenme olguları, yoğun bakım ünitelerinde (YBÜ) takip ve tedavi gerektiren bir sorundur. Bu çalışmada, YBÜ'deki SK zehirlenmesi olgularının klinik seyir ve sonuçlarını tartışmayı amaçladık.Gereç ve Yöntem: 2014-2017 yılları arasında Ordu Devlet Hastanesi Reanimasyon Yoğun Bakım Ünitesi'nde takip ve tedavi edilen 19 hastanın (16 erkek, 3 kadın) dosyaları retrospektif olarak tarandı.Bulgular: SK kullandıkları kendisi, yakınları ya da görgü tanıkları tarafından doğrulanan hastaların ortalama yaşı 20.1 ve çoğu erkekti. Hastalarda en sık rastlanan bulgular huzursuzluk, saldırganlık, taşıkardi, lökositoz, karaciğer fonksiyon testlerinde yükseklik olarak saptandı. Ayrıca işitsel-görsel halusinasyon, bilinç bulanıklığı, koma hâli görüldü. On sekiz hasta taburcu olurken, 1 hasta eks oldu Sonuç: SK intoksikasyonunun spesifik tedavisi yoktur, tedavi semptomatiktir ve gelişen komplikasyona yöneliktir. Günümüzde uyuşturucu madde ticaretinde artan çeşitlilik, psikoaktif etkili yeni maddelerin piyasada artışına neden olmuştur. Acil servise intoksikasyon bulgularıyla getirilen uyuşturucu paneli negatif çıkan hastalarda, SK kullanımı şüphesi ayırıcı tanıda düşünülmeli ve semptomatik tedaviye erken başlanmalıdır.

🔖

Cite This Article

KARACA, Ö., ATAN, Ç., ÇOLAK, M. F., ERTÜRK, E. Y., SOLAK, S. K., VURAL, A. Y., CEYLAN, P., KAZİ, S., DEMİRGAN, S. (2022). Retrospective Analysis of Patients with Bonzai Toxicity Hospitalized in Intensive Care Unit. İstanbul Kanuni Sultan Süleyman Tıp Dergisi, Cilt: 10 - Sayı: 1, 7–11. https://ajindex.com/articles/551045

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL."Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict. 2012:21:320-6.
  2. Tomiyama K, Funada M. Cytotoxicity of synthetic cannabinoids found in "Spice" products: the role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line. Toxicology Lett 2011;207:12-7.
  3. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003;42: 327-60.
  4. Geller T. Cannabinoids:a secret history. Chem Herit Newsmagazine 2007:25(2
  5. Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 2014;144:12- 41.
  6. EMCDDA, 2009a. Early-warning system. Understanding the 'Spice'phenomenon. Erişim tarihi: 15.03.2015
  7. UNDOC, Syntheticcannabinoids in herbal products. United Nations Office on Drugs and Crime, 2011. http://www.unodc.org/documents/ scientific/Synthetic_ Cannabinoids.pdf. Erişim tarihi:21.03.2015 8. Hu X, Primack BA, Barnett TE, Cook RL. College students and the use of K2: An emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy 2011;6:16.
  8. Barratt MJ, Cakic V, Lenton S. Patterns of synthetic cannabinoid use in Australia. Drug Alcohol Rev. 2013; 32:141-6.
  9. Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend. 2012;120:238- 41.
  10. Hoyte CO, Jacob J, Monte AA, et al. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med 2012;60:435-8.
  11. Küçük E, Küçük İ, Kirazaldı YY. Acil serviste yeni bir tehlike; Sentetik kannabinoidler (Bonzai, Jameika) Genel Tıp Derg. 2015;25:18-22.
  12. Evren C, Bozkurt M. Sentetik Kannabinoidler: Son yılların krizi. Düşünen Adam 2013;26:1-11
  13. Yeni Nesil Psiko-aktif Maddeler Sempozyumu. 26 Kasım 2013.